Biotechnology
Cancer
Therapies
Unitedstates
Confidential
Offering
Stock
Geron
M&A Advisory
Lazard
Full Credential Description
Geron. United States. Announced Date 30/01/2014. Closed Date 04/02/2014. Deal value: $104m. Confidentially marketed public offering of common stock. Industry: Geron is a biotechnology company focused on developing therapies for cancer.